Form 8-K - Current report:
SEC Accession No. 0001193125-25-025057
Filing Date
2025-02-12
Accepted
2025-02-12 15:28:48
Documents
22
Period of Report
2025-02-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d868986d8k.htm   iXBRL 8-K 50844
2 EX-1.1 d868986dex11.htm EX-1.1 266745
3 EX-4.3 d868986dex43.htm EX-4.3 227821
4 EX-5.1 d868986dex51.htm EX-5.1 15228
5 EX-5.2 d868986dex52.htm EX-5.2 11686
10 GRAPHIC g868986dsp138.jpg GRAPHIC 4117
11 GRAPHIC g868986dsp139.jpg GRAPHIC 2368
12 GRAPHIC g868986g0211121418746.jpg GRAPHIC 2698
13 GRAPHIC g868986g0211221026253.jpg GRAPHIC 1744
  Complete submission text file 0001193125-25-025057.txt   921305

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lly-20250210.xsd EX-101.SCH 5931
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20250210_def.xml EX-101.DEF 16470
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20250210_lab.xml EX-101.LAB 28466
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20250210_pre.xml EX-101.PRE 17957
25 EXTRACTED XBRL INSTANCE DOCUMENT d868986d8k_htm.xml XML 15880
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 25614489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)